BioCentury
ARTICLE | Financial News

Finch Therapeutics raises $36 million series B round

March 2, 2018 5:33 PM UTC

Finch Therapeutics Group Inc. (Somerville, Mass.) raised $36 million on March 1 in an oversubscribed series B round from Shumway Capital, Willett Advisors, Morgan Noble and Avenir Growth Capital. The original target was $30 million.

CEO Mark Smith told BioCentury the financing will provide Finch with runway into 2019. The microbiome therapeutics company has raised $77 million to date...